Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation.
about
T Lymphocyte-Endothelial Interactions: Emerging Understanding of Trafficking and Antigen-Specific ImmunityClinical usefulness of novel serum and imaging biomarkers in risk stratification of patients with stable anginaThe influence of innate and adaptive immune responses on atherosclerosisT cell costimulatory and coinhibitory pathways in vascular inflammatory diseasesLymphocyte activation gene 3 and coronary artery diseaseMyocardial ischemia and reperfusion leads to transient CD8 immune deficiency and accelerated immunosenescence in CMV-seropositive patientsThe mutual interplay of lipid metabolism and the cells of the immune system in relation to atherosclerosisProgrammed cell death-1 deficiency exacerbates T cell activation and atherogenesis despite expansion of regulatory T cells in atherosclerosis-prone mice.Upregulation of Programmed Death-1 and Its Ligand in Cardiac Injury Models: Interaction with GADD153.PD-1 and Tim-3 Pathways Regulate CD8+ T Cells Function in AtherosclerosisPD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis.Adaptive immunity in atherogenesis: new insights and therapeutic approaches.Attenuation of the programmed cell death-1 pathway increases the M1 polarization of macrophages induced by zymosanAltered Maturation Status and Possible Immune Exhaustion of CD8 T Lymphocytes in the Peripheral Blood of Patients Presenting With Acute Coronary Syndromes.A Century of Radiation Therapy and Adaptive ImmunityMolecular biology of atherosclerosis.Atheroprotective immunity and cardiovascular disease: therapeutic opportunities and challenges.Regulation of atherosclerotic plaque inflammation.ATVB Distinguished Scientist Award: How Costimulatory and Coinhibitory Pathways Shape Atherosclerosis.Readapting the adaptive immune response - therapeutic strategies for atherosclerosis.Impact of Immune Deficiency on Remodeling of Maternal Resistance Vasculature 4 Weeks Postpartum in Mice.Immune checkpoint dysfunction in large and medium vessel vasculitis.Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis.Dynamic immune cell accumulation during flow-induced atherogenesis in mouse carotid artery: an expanded flow cytometry methodAtherosclerosis-Driven Treg Plasticity Results in Formation of a Dysfunctional Subset of Plastic IFNγ+ Th1/Tregs.PD-1 blockage delays murine squamous cell carcinoma development.Exploring immune checkpoints as potential therapeutic targets in atherosclerosis.Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects.Marginal zone B cells control the response of follicular helper T cells to a high-cholesterol diet.Oral administration of the lactic acid bacterium Pediococcus acidilactici attenuates atherosclerosis in mice by inducing tolerogenic dendritic cells.The human blood DNA methylome identifies crucial role of β-catenin in the pathogenesis of Kawasaki disease.
P2860
Q26774645-BD7C1FA4-98AB-4992-88EF-273F0B27EFA4Q26859111-32051D24-8B15-46D0-89BE-C716F533EE9AQ27000370-53D48C6D-36F6-4866-BF63-EC536B5E3EF5Q28396774-60C5F578-6A49-4162-AFAF-4400611506DBQ30275618-6F58FE99-D5A9-4306-A4F4-FF418B2F41B7Q34790920-56F97BA2-6CAC-407D-A2A6-9E5A592196E8Q35104236-D47DC0C4-84EB-48C6-B893-BB43D4BCD5E4Q35137584-E1F14EC5-2AAC-4691-9FC6-D360DE1C318EQ35611631-2CE8D9F5-D76B-471C-9F3E-5BE5C2C53A7BQ35649732-30118142-6AA7-4288-B430-A908343678C0Q35936041-2845967B-30F4-4761-81CD-6C3DF20A2F4AQ36497196-8DA19235-5982-4300-91BA-4844CD3A1AFDQ36847545-403DBF84-C49E-417A-B8DD-41E3EEC2A12EQ37365537-FA074A78-4D8E-405C-BFD2-1BAA795DB4D0Q37747153-72C19BB5-E382-4CC4-AB6C-1B60898B2699Q38125279-AA1B4F33-5147-4D5C-B866-9A3C37E8C510Q38346930-ADB31067-244B-4428-B53D-E9F857BF4321Q38396097-514DF910-A6C5-4268-A1FC-C7089821F838Q38737500-9D968C53-C99A-4AE2-829E-EB89DE2EE2EDQ38774904-8CD643F1-F053-4D00-8209-93C6C092AAE8Q38789230-1817F9C4-A6C9-4832-924D-F0ECF4DF473CQ38897019-1F645939-E0E9-4BC4-9419-B8E326AC61FDQ39215639-3997D1CE-3E4C-42E0-84B3-2A57B739FBD4Q42134468-6B19A0C0-E455-4696-9F78-ACA569910F14Q43273026-6F53A6AB-8C5B-4DB0-97CB-4D6AC0ADA5B4Q44360014-68AB8D53-02EB-49AF-AD26-86657D931741Q47224948-0C3A3FDE-D103-4387-9594-A89717253FCDQ47239900-DCF40DF1-DB92-4C81-A53E-AEC3EE611E5AQ48270888-8459A038-4CF6-4B76-BDF7-10C6E0791E6AQ52792704-D33F8267-2FAE-46F2-9335-DE4EC429B090Q55504414-067753ED-9E1C-47BB-8E30-5A9C6A775527
P2860
Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Impairment of the programmed c ...... development and inflammation.
@ast
Impairment of the programmed c ...... development and inflammation.
@en
type
label
Impairment of the programmed c ...... development and inflammation.
@ast
Impairment of the programmed c ...... development and inflammation.
@en
prefLabel
Impairment of the programmed c ...... development and inflammation.
@ast
Impairment of the programmed c ...... development and inflammation.
@en
P2093
P2860
P1476
Impairment of the programmed c ...... development and inflammation.
@en
P2093
Andrew H Lichtman
Arlene H Sharpe
Elena Maganto-Garcia
George Stavrakis
Gordon J Freeman
Goro Tajima
James Lederer
Margarite Tarrio
Petr Jarolim
P2860
P304
P356
10.1161/ATVBAHA.111.224709
P407
P577
2011-03-10T00:00:00Z